Not Just Patients

Mobilising Meaningful Pharma-Patient Collaboration┃Bronwyn Lewis

May 20, 2024 Caitlin and Clarinda with Bronwyn Lewis
Mobilising Meaningful Pharma-Patient Collaboration┃Bronwyn Lewis
Not Just Patients
More Info
Not Just Patients
Mobilising Meaningful Pharma-Patient Collaboration┃Bronwyn Lewis
May 20, 2024
Caitlin and Clarinda with Bronwyn Lewis

On this episode, we speak with Bronwyn Lewis, Global Head of Patient Engagement at Boehringer Ingelheim.

Drawing on her 20+ years of experience across diverse roles in the pharmaceutical industry, Bronwyn offers deep insights into how the industry is perceiving and  responding to the call for deeper patient engagement, the challenges and opportunities for better multi-stakeholder collaboration, and her vision for the future.

Note: In the episode, Bronwyn mentions  Boehringer Ingelheim’s Research & Development (R&D) investment data for the year 2022. In 2023, Boehringer Ingelheim’s R&D investments increased by 14.2% to EUR 5.8 billion. R&D investments were substantial, at 22.5% of net sales (source: Boehringer Ingelheim strong growth pipeline acceleration 2023 | Boehringer Ingelheim (boehringer-ingelheim.com)).

Chapters

  • 00:00 - Introductions
  • 01:03 - Defining patient engagement from the industry perspective
  • 04:06 - Bronwyn's journey into patient engagement
  • 06:51 - The Patient Engagement function at Boehringer Ingelheim
  • 10:39 - Composition of Patient Engagement teams in pharma    
  • 13:22 - Aligning the motivations of pharma and patient groups
  • 16:42 - Barriers to pharma–patient collaboration
  • 20:23 - Justifying return on investment (ROI) 
  • 26:17 - Patient engagement touchpoints and activities
  • 29:16 - Matching best-fit patients to targeted activities 
  • 32:21 - Systemic integration of patient insights into all pharma operations 
  • 36:25 - Examples of patient insights influencing decisions
  • 38:28 - Boehringer Ingelheim's Global Patient Partnership Summit
  • 44:26 - Collaboration among industry stakeholders
  • 47:56 - Visualizing the future
  • 56:14 - Advice for patients and industry stakeholders 
  • 58:13 - Reflections with Caitlin and Clarinda


Resources and abbreviations mentioned

Have feedback or suggestions for us? We'd love to hear from you!
Website: notjustpatients.com
LinkedIn: Not Just Patients
Email: info@notjustpatients.com

Show Notes Chapter Markers

On this episode, we speak with Bronwyn Lewis, Global Head of Patient Engagement at Boehringer Ingelheim.

Drawing on her 20+ years of experience across diverse roles in the pharmaceutical industry, Bronwyn offers deep insights into how the industry is perceiving and  responding to the call for deeper patient engagement, the challenges and opportunities for better multi-stakeholder collaboration, and her vision for the future.

Note: In the episode, Bronwyn mentions  Boehringer Ingelheim’s Research & Development (R&D) investment data for the year 2022. In 2023, Boehringer Ingelheim’s R&D investments increased by 14.2% to EUR 5.8 billion. R&D investments were substantial, at 22.5% of net sales (source: Boehringer Ingelheim strong growth pipeline acceleration 2023 | Boehringer Ingelheim (boehringer-ingelheim.com)).

Chapters

  • 00:00 - Introductions
  • 01:03 - Defining patient engagement from the industry perspective
  • 04:06 - Bronwyn's journey into patient engagement
  • 06:51 - The Patient Engagement function at Boehringer Ingelheim
  • 10:39 - Composition of Patient Engagement teams in pharma    
  • 13:22 - Aligning the motivations of pharma and patient groups
  • 16:42 - Barriers to pharma–patient collaboration
  • 20:23 - Justifying return on investment (ROI) 
  • 26:17 - Patient engagement touchpoints and activities
  • 29:16 - Matching best-fit patients to targeted activities 
  • 32:21 - Systemic integration of patient insights into all pharma operations 
  • 36:25 - Examples of patient insights influencing decisions
  • 38:28 - Boehringer Ingelheim's Global Patient Partnership Summit
  • 44:26 - Collaboration among industry stakeholders
  • 47:56 - Visualizing the future
  • 56:14 - Advice for patients and industry stakeholders 
  • 58:13 - Reflections with Caitlin and Clarinda


Resources and abbreviations mentioned

Have feedback or suggestions for us? We'd love to hear from you!
Website: notjustpatients.com
LinkedIn: Not Just Patients
Email: info@notjustpatients.com

Introductions
Defining patient engagement from the industry perspective
Bronwyn's journey into patient engagement
The Patient Engagement function at Boehringer Ingelheim
Composition of Patient Engagement teams in pharma
Aligning the motivations of pharma and patient groups
Barriers to pharma–patient collaboration
Justifying return on investment (ROI)
Patient engagement touchpoints and activities
Matching best-fit patients to targeted activities
Systemic integration of patient insights into all pharma operations
Examples of patient insights influencing decisions
Boehringer Ingelheim's Global Patient Partnership Summit
Collaboration among industry stakeholders
Visualizing the future
Advice for patients and industry stakeholders
Reflections with Caitlin and Clarinda